Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Employer
- City of Hope
- National University of Singapore
- Indiana University
- Nanyang Technological University
- University of British Columbia
- University of Maryland, Baltimore
- Zintellect
- University of Oslo
- Harvard University
- Center for Biologics Evaluation and Research (CBER)
- University of Michigan
- Cellular and Molecular Therapeutics Branch, NHLBI, NIH
- Cold Spring Harbor Laboratory
- Cold Spring Harbor Laboratory (CSHL)
- Cori Institute of Molecular and Computational Metabolism
- Dana-Farber Cancer Institute (DFCI)
- Duke-NUS
- Eisbach Bio GmbH
- H. Lee Moffitt Cancer Center & Research Institute
- Instituto de Investigação e Inovação em Saúde da Universidade do Porto (i3S)
- Missouri University of Science and Technology
- Research Center for Molecular Medicine (CeMM), ÖAW
- The Jiang Lab, The Icahn School of Medicine at Mount Sinai
- The University of Texas Southwestern Medical Center (UT Southwestern Medical Center)
- Tokyo University of Science
- University of Colorado
- University of Kansas Medical Center
- University of North Carolina
- University of North Carolina at Charlotte
- University of Nottingham
- University of Oklahoma Health Campus
- Université de Strasbourg
- eQuest
- 23 more »
- « less
-
Field
-
, CRISPR screening, and human disease systems. This is an opportunity to pursue high-impact, discovery-driven research in a rapidly expanding field, lead publications, build an independent scientific profile
-
." • Develop and apply human pluripotent stem cell-derived kidney organoid models, CRISPR-Cas9 genome editing, and molecular and cellular biology techniques to investigate disease mechanisms. • Perform and
-
. The successful candidate should have extensive experience from experimental laboratory work in molecular cell biology using techniques such as cell culture, CRISPR/Cas9 based genome editing, protein expression and
-
development and human diseases, such as neurological disorder, immunology, and cancer. Utilize biochemistry, molecular biology, CRISPR-based genomic screen, single-cell transcriptomics, and genetically modified
-
-throughput CRISPR-based functional genomics approaches, we systematically identify genes and pathways that enable tumor cells to evade immune attack, providing new targets for therapeutic intervention and
-
progression. The successful candidate should have extensive experience from experimental laboratory work in molecular cell biology using techniques such as cell culture, CRISPR/Cas9 based genome editing
-
The Jiang Lab, The Icahn School of Medicine at Mount Sinai | New York City, New York | United States | 2 months ago
primary cell culture. Experience in lung-targeted mouse studies (e.g., intranasal/intratracheal deliver, and airway biology) is highly preferred. The goal of our lab is to evolve CRISPR-based genome editing
-
experimental laboratory work in molecular cell biology using techniques such as cell culture, CRISPR/Cas9 based genome editing, protein expression and interaction analysis, light microscopy and/or cancer assays
-
, astrocytes, oligodendrocytes, and microglia. Develop complex neuroimmune co-culture systems incorporating immune cells into human CNS models. Apply CRISPR/Cas-based genome engineering technologies
-
· CRISPR Knockout and knock in techniques · Ability to plot and interpret data and come up with follow up experiments · Demonstrates mastery of time management · Maintains a high degree of professionalism